Artegraft, Inc.

Click Here To EMAIL INQUIRY
Contact: Richard A. Gibson - President & CEO
Web: http://www.artegraft.com
E-Mail:
Address: 220 N. Center Drive, North Brunswick, New Jersey 8902, USA
Phone: +1-(732)-422-8333, 800-631-5264 | Fax: +1-(732)-422-8647 | Map/Directions >>

Profile: Artegraft, Inc. specializes in offering Collagen Vascular Graft™. Artegraft is a natural collagen vascular graft. Its biological fibrous matrix is processed to enhance long term patency and provide a tightly woven, cross-linked conduit that is flexible & compliant. It is used for segmental bypass, arterial replacement, patch graft, and femoropopliteal bypass when the patient's saphenous is absent or inadequate, but is predominantly used as a hemodialysis graft. It is a Class III, life-sustaining implantable device. It is indicated for use distal to the aorta as an A-V shunt, segmental arterial replacement, arterial bypass, arterial patch and femoropopliteal bypass when saphenous vein is absent or inadequate.

The company was founded in 1993, has revenues of USD 1-5 Million.

FDA Registration Number: 2247686

4 Products/Services (Click for related suppliers)

• Catheter Introducers (FDA Code: DYB / 870.1340)

A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.

• Embolectomy Catheters (FDA Code: DXE / 870.5150)

An embolectomy catheter is a balloon-tipped catheter that is used to remove thromboemboli, i.e., blood clots which have migrated in blood vessels from one site in the vascular tree to another.

• Tissue Graft (FDA Code: LXA)

• Vascular Grafts